The Safety, Tolerability and Pharmacokinetics Study of RAY1216 in Healthy Adult Participants
Status:
Completed
Trial end date:
2022-08-12
Target enrollment:
Participant gender:
Summary
This is double-blind,randomized, single and multiple dose trial to evaluate the
pharmacokinetics(PK), safety, tolerability and drug-drug interaction of RAY1216, and the
effect of food on RAY1216 Pharmacokinetics.